Pear Therapeutics
Agent21Agent Readiness: 21/100. Bottom 25%. Measured by StartupHub.ai. Median 41.Pioneered prescription digital therapeutics for serious diseases, integrating software with pharmaceuticals.
About
Pear Therapeutics was a leader in developing and commercializing prescription digital therapeutics (PDTs), which are FDA-cleared software applications designed to treat serious diseases. Their approach integrated clinically validated software with pharmaceuticals to improve patient outcomes, provide clinician tools, and offer cost-effective solutions for payers. The company aimed to redefine care through the widespread use of these software-based therapeutics.
Key facts
At-a-glance profile data
- Website
- peartherapeutics.com
- Headquarters
- Boston, United States
- Founded
- 2013
- Total funding
- $409M (Post-IPO Equity)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Post-money | Lead investors |
|---|---|---|---|---|
| 1 Dec 2021 | Post-IPO Equity | $125M | $1.6B | - |
| 1 Mar 2021 | Series D | $20M | - | - |
| 1 Dec 2020 | Series D | $80M | - | Softbank |
| 1 Jul 2020 | Debt Financing | $50M | - | Perceptive Advisors |
| 1 Jan 2019 | Series C | $64M | - | Temasek Holdings |
| 1 Jan 2018 | Series B | $50M | - | Temasek Holdings |
| 1 Feb 2016 | Series A | $20M | - | 5AM Ventures, Jazz Venture Partners |
Tech stack
Detected on peartherapeutics.com, last scanned 23 May 2026. Run your own scan
- Hosting
- Google Cloud
- Email provider
- Google Workspace
Frequently asked
How much funding has Pear Therapeutics raised?
Pear Therapeutics has raised a total of $409M in funding. The most recent round on record is Post-IPO Equity.
What is Pear Therapeutics's current status?
Pear Therapeutics's current operating status is: Inactive.